Contact
searchSearch
HMP Global

Peripheral Arterial Disease Topic Center

Features

KJ Nagarsheth, MD
Sponsored
Optimizing Outcomes in Complex PAD: Dr. Nagarsheth on DETOUR Integration and Patient Selection
09/23/2025
Khanjan Nagarsheth, MD, MBA, RPVI
Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system.
Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system.
Join Dr. KJ Nagarsheth as he...
09/23/2025
Vascular Disease Management
Sonya Noor, MD
Sponsored
Transforming Complex PAD Treatment With PTAB Therapy: Dr. Sonya Noor Shares Her Perspective
09/23/2025
Sonya Noor, MD
In this video from AMP 2025, vascular surgeon Dr. Sonya Noor discusses the evolving landscape of treating complex PAD.
In this video from AMP 2025, vascular surgeon Dr. Sonya Noor discusses the evolving landscape of treating complex PAD.
In this video from AMP 2025,...
09/23/2025
Vascular Disease Management
Case Report
Limb Salvage in Complex Femoropopliteal Occlusion
09/22/2025
John H. Shao, MD; John Lee, MD; Haris Umer Usman, MD, MS
The authors describe the successful application of PTAB utilizing the Detour system (Endologix) as a limb salvage strategy for a patient with previously failed femoropopliteal bypass.
The authors describe the successful application of PTAB utilizing the Detour system (Endologix) as a limb salvage strategy for a patient with previously failed femoropopliteal bypass.
The authors describe the...
09/22/2025
Vascular Disease Management
Original Contribution
Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study
09/19/2025
Darshan Randhawa, MD; Samuel Thomas; Michael Siah, MD
The authors outline the clinical burden of CLTI, explain the LimFlow procedure, and review evidence from the CLariTI and PROMISE studies supporting its use in "no-option" patients.
The authors outline the clinical burden of CLTI, explain the LimFlow procedure, and review evidence from the CLariTI and PROMISE studies supporting its use in "no-option" patients.
The authors outline the clinical...
09/19/2025
Vascular Disease Management
Interview
A Literature Review of Atherectomy for Peripheral Interventions
09/19/2025
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his...
09/19/2025
Vascular Disease Management
Video
Saving Limbs, Saving Lives, and Reducing Healthcare Costs With DVA
09/19/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Clinical Editor Craig Walker, MD, comments on an article from the September issue article entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study."
In this video, Clinical Editor Craig Walker, MD, comments on an article from the September issue article entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study."
In this video, Clinical Editor...
09/19/2025
Vascular Disease Management
Editor's Corner
DVA Shows Great Promise in Saving Limbs, Saving Lives, and Reducing Healthcare Costs
09/19/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on the article by Randhawa, Thomas, and Siah entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study”.
Dr Walker comments on the article by Randhawa, Thomas, and Siah entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study”.
Dr Walker comments on the...
09/19/2025
Vascular Disease Management
Mike Watts, MD
AMP 2025
Will AI and Wearables Change the Future of CLTI Therapy?
09/18/2025
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses...
09/18/2025
Vascular Disease Management
Dr Madassery
AMP 2025
CLTI Imaging: When and What I Look at Before Angio and on the Angio
09/10/2025
Kumar Madassery, MD
Dr Kumar Madassery discusses his AMP 2025 presentation on angiography for patients with chronic limb-threatening ischemia.
Dr Kumar Madassery discusses his AMP 2025 presentation on angiography for patients with chronic limb-threatening ischemia.
Dr Kumar Madassery discusses his...
09/10/2025
Vascular Disease Management
Bret Wiechmann, MD
OBL Corner
Is There an Optimal Site of Service for CLTI Intervention: Hospital, ASC, or OBL?
09/04/2025
Bret N. Wiechmann, MD, FSIR, FAHA; Mike Watts, MD, FSIR
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike...
09/04/2025
Vascular Disease Management

Videos

KJ Nagarsheth, MD
Sponsored
Optimizing Outcomes in Complex PAD: Dr. Nagarsheth on DETOUR Integration and Patient Selection
09/23/2025
Khanjan Nagarsheth, MD, MBA, RPVI
Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system.
Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system.
Join Dr. KJ Nagarsheth as he...
09/23/2025
Vascular Disease Management
Sonya Noor, MD
Sponsored
Transforming Complex PAD Treatment With PTAB Therapy: Dr. Sonya Noor Shares Her Perspective
09/23/2025
Sonya Noor, MD
In this video from AMP 2025, vascular surgeon Dr. Sonya Noor discusses the evolving landscape of treating complex PAD.
In this video from AMP 2025, vascular surgeon Dr. Sonya Noor discusses the evolving landscape of treating complex PAD.
In this video from AMP 2025,...
09/23/2025
Vascular Disease Management
Video
Saving Limbs, Saving Lives, and Reducing Healthcare Costs With DVA
09/19/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Clinical Editor Craig Walker, MD, comments on an article from the September issue article entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study."
In this video, Clinical Editor Craig Walker, MD, comments on an article from the September issue article entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study."
In this video, Clinical Editor...
09/19/2025
Vascular Disease Management
Mike Watts, MD
AMP 2025
Will AI and Wearables Change the Future of CLTI Therapy?
09/18/2025
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses...
09/18/2025
Vascular Disease Management
Dr Madassery
AMP 2025
CLTI Imaging: When and What I Look at Before Angio and on the Angio
09/10/2025
Kumar Madassery, MD
Dr Kumar Madassery discusses his AMP 2025 presentation on angiography for patients with chronic limb-threatening ischemia.
Dr Kumar Madassery discusses his AMP 2025 presentation on angiography for patients with chronic limb-threatening ischemia.
Dr Kumar Madassery discusses his...
09/10/2025
Vascular Disease Management
Bret Wiechmann, MD
OBL Corner
Is There an Optimal Site of Service for CLTI Intervention: Hospital, ASC, or OBL?
09/04/2025
Bret N. Wiechmann, MD, FSIR, FAHA; Mike Watts, MD, FSIR
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike...
09/04/2025
Vascular Disease Management
Dr Anahita Dua
VAM25
Comparison of Long-term Outcomes Between TADV vs Standard of Care Therapy for No-Option CLTI Patients
06/19/2025
Anahita Dua, MD, MS, MBA, FACS
Dr Anahita Dua shares background and insights on her abstract of the same name presented at VAM25 in New Orleans.
Dr Anahita Dua shares background and insights on her abstract of the same name presented at VAM25 in New Orleans.
Dr Anahita Dua shares background...
06/19/2025
Vascular Disease Management
Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
Dr Jay Mathews
ISET 2025
DETOUR Patient Selection in Complex PAD: Expert Insights from Dr. Jay Mathews
03/24/2025
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the...
03/24/2025
Vascular Disease Management
Dr Daniel Clair
ISET 2025
First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the FORWARD IDE and Feasibility Studies
03/17/2025
Daniel G. Clair, MD
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, ...
03/17/2025
Vascular Disease Management
Dr Prologo
Sponsored Video
Dual-Level Kyphoplasty With OsteoCool 2.0: Simultaneous Ablation and Cementation Guided by Dr Prologo
09/26/2025
J. David Prologo, MD, FSIR
Join Dr Prologo for a groundbreaking look at a dual-level kyphoplasty procedure using the OsteoCool 2.0 system. This exclusive video captures real-time ablation and cement injection at two vertebral levels with 10-gauge cannulas, complete...
Join Dr Prologo for a groundbreaking look at a dual-level kyphoplasty procedure using the OsteoCool 2.0 system. This exclusive video captures real-time ablation and cement injection at two vertebral levels with 10-gauge cannulas, complete...
Join Dr Prologo for a...
09/26/2025
Vascular Disease Management
KJ Nagarsheth, MD
Sponsored
Optimizing Outcomes in Complex PAD: Dr. Nagarsheth on DETOUR Integration and Patient Selection
09/23/2025
Khanjan Nagarsheth, MD, MBA, RPVI
Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system.
Join Dr. KJ Nagarsheth as he reflects on his experience with PTAB Therapy using the DETOUR™ system.
Join Dr. KJ Nagarsheth as he...
09/23/2025
Vascular Disease Management
Sonya Noor, MD
Sponsored
Transforming Complex PAD Treatment With PTAB Therapy: Dr. Sonya Noor Shares Her Perspective
09/23/2025
Sonya Noor, MD
In this video from AMP 2025, vascular surgeon Dr. Sonya Noor discusses the evolving landscape of treating complex PAD.
In this video from AMP 2025, vascular surgeon Dr. Sonya Noor discusses the evolving landscape of treating complex PAD.
In this video from AMP 2025,...
09/23/2025
Vascular Disease Management
Video
Saving Limbs, Saving Lives, and Reducing Healthcare Costs With DVA
09/19/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Clinical Editor Craig Walker, MD, comments on an article from the September issue article entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study."
In this video, Clinical Editor Craig Walker, MD, comments on an article from the September issue article entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study."
In this video, Clinical Editor...
09/19/2025
Vascular Disease Management
Mike Watts, MD
AMP 2025
Will AI and Wearables Change the Future of CLTI Therapy?
09/18/2025
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses...
09/18/2025
Vascular Disease Management
Dr Madassery
AMP 2025
CLTI Imaging: When and What I Look at Before Angio and on the Angio
09/10/2025
Kumar Madassery, MD
Dr Kumar Madassery discusses his AMP 2025 presentation on angiography for patients with chronic limb-threatening ischemia.
Dr Kumar Madassery discusses his AMP 2025 presentation on angiography for patients with chronic limb-threatening ischemia.
Dr Kumar Madassery discusses his...
09/10/2025
Vascular Disease Management
Bret Wiechmann, MD
OBL Corner
Is There an Optimal Site of Service for CLTI Intervention: Hospital, ASC, or OBL?
09/04/2025
Bret N. Wiechmann, MD, FSIR, FAHA; Mike Watts, MD, FSIR
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike...
09/04/2025
Vascular Disease Management
Dr Gable
Sponsored Video
Dennis Gable, MD, Shares His Perspective on Real-World, 5-Year TEVAR Outcomes
09/01/2025
Dennis Gable, MD
Dr Gable shares his perspective on the recently published 5-year follow-up outcomes of the GREAT Registry.
Dr Gable shares his perspective on the recently published 5-year follow-up outcomes of the GREAT Registry.
Dr Gable shares his perspective...
09/01/2025
Vascular Disease Management
JLevy headshot
Video
Percutaneous Ablation for Vertebral Metastases
08/11/2025
Jason Levy, MD, FSIR
Dr Jason Levy discusses the clinical considerations, procedural techniques, and the ongoing evidence in the use of percutaneous ablation for treating vertebral metastases.
Dr Jason Levy discusses the clinical considerations, procedural techniques, and the ongoing evidence in the use of percutaneous ablation for treating vertebral metastases.
Dr Jason Levy discusses the...
08/11/2025
Vascular Disease Management
Drs Garg and Sayfo
Sponsored Video
Shockwave Javelin: Dr. Garg and Dr. Sayfo Discussion and Case Review at ISET 2025
07/07/2025
Dr. Karan Garg and Dr. Sameh Sayfo discuss the novel Shockwave Javelin Peripheral catheter, the first of its kind on a Forward IVL platform.
Dr. Karan Garg and Dr. Sameh Sayfo discuss the novel Shockwave Javelin Peripheral catheter, the first of its kind on a Forward IVL platform.
Dr. Karan Garg and Dr. Sameh...
07/07/2025
Vascular Disease Management

Presentations

Dr Brodmann
AMP 2025
Transradial Access Shifts the Paradigm in Treating Chronic Limb-Threatening Ischemia
08/14/2025
Marianne Brodmann, MD
Marianne Brodmann, MD, delivered a detailed update on how she employs radial artery access to manage chronic limb-threatening ischemia.
Marianne Brodmann, MD, delivered a detailed update on how she employs radial artery access to manage chronic limb-threatening ischemia.
Marianne Brodmann, MD, delivered...
08/14/2025
Vascular Disease Management
Dr Pliagas
AMP 2025
How IVUS Changed My Intervention
08/14/2025
George Pliagas, MD, FACS, FRCSC
During Thursday’s “Diagnosis and Imaging in CLTI” session, George Pliagas, MD, FACS, FRCSC, shared how IVUS has reshaped his approach to treating peripheral vascular disease.
During Thursday’s “Diagnosis and Imaging in CLTI” session, George Pliagas, MD, FACS, FRCSC, shared how IVUS has reshaped his approach to treating peripheral vascular disease.
During Thursday’s “Diagnosis and...
08/14/2025
Vascular Disease Management
Dr Tokuda
AMP 2025
Atherectomy + DCB vs Stent-Based Repair for Severely Calcified Femoropopliteal Disease
08/13/2025
Takahiro Tokuda, MD
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro...
08/13/2025
Vascular Disease Management
Dr Zeller
AMP 2025
WOUNDSinCLTI Trial Update: Pathogen-Driven Insights Into Limb Salvage in CLTI
08/13/2025
Thomas Zeller, MD, PhD
Thomas Zeller, MD, from the Universitaets-Herzzentrum Freiburg, Bad Krozingen, Germany, presented the inaugural findings from the WOUND infection and clinical outcomeS IN patients with Chronic Limb-Threatening Ischemia (WOUNDSinCLTI) study,
Thomas Zeller, MD, from the Universitaets-Herzzentrum Freiburg, Bad Krozingen, Germany, presented the inaugural findings from the WOUND infection and clinical outcomeS IN patients with Chronic Limb-Threatening Ischemia (WOUNDSinCLTI) study,
Thomas Zeller, MD, from the...
08/13/2025
Vascular Disease Management
Dr van den Berg
AMP 2025
Jos van den Berg, MD, PhD, Highlights the Growing Economic Burden of CLTI in Europe
08/13/2025
Jos C. van den Berg, MD, PhD
During Wednesday morning’s “CLTI in 2025” session, interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
During Wednesday morning’s “CLTI in 2025” session, interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
During Wednesday morning’s “CLTI...
08/13/2025
Vascular Disease Management
Dr Richard Neville
AMP 2025
Evolving Metrics: Dr Richard Neville Explains How Quality Assessment in CLTI Care Is Being Re-Engineered
08/13/2025
Richard Neville, MD
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines...
08/13/2025
Vascular Disease Management
Dr Brodmann
ISET 2025
Current State of Paclitaxel Drug-Coated Balloons and Drug-Eluting Stents
02/04/2025
Marianne Brodmann, MD
Marianne Brodmann, MD, presented an in-depth review of drug-coated balloons and drug-eluting stents for treating peripheral arterial disease.
Marianne Brodmann, MD, presented an in-depth review of drug-coated balloons and drug-eluting stents for treating peripheral arterial disease.
Marianne Brodmann, MD, presented...
02/04/2025
Vascular Disease Management
Dr Yeung
ISET 2025
The Treatment of PAD and the Role of AI
02/03/2025
Kak Khee Yeung, MD, from Amsterdam UMC in the Netherlands, gave a presentation at ISET 2025 that explored the integration of artificial intelligence into the treatment of peripheral arterial disease.
Kak Khee Yeung, MD, from Amsterdam UMC in the Netherlands, gave a presentation at ISET 2025 that explored the integration of artificial intelligence into the treatment of peripheral arterial disease.
Kak Khee Yeung, MD, from...
02/03/2025
Vascular Disease Management
Dr Babaev
ISET 2025
Thirty-Day Outcomes From the Disrupt PAD BTK II Study
01/31/2025
Anvar Babaev, MD, PhD
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD,...
01/31/2025
Vascular Disease Management
Dr Kolluri
LINC 2025
The Case for Duplex Endpoints
01/29/2025
Raghu Kolluri, MS, MD, RVT, FSVM
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for...
01/29/2025
Vascular Disease Management
Teri Yates
AMP 2025
The Pros and Cons of OBLs and ASCs
08/15/2025
Teri Yates
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable...
08/15/2025
Vascular Disease Management
Earl Johnson MD
AMP 2025
Plastic Surgery: Enhancing Outcomes Through Early Involvement
08/15/2025
Earl M. Johnson, Jr., MD, FACS
Earl M. Johnson, Jr., MD, FACS, presented a discussion on the transformative role plastic surgery can play when incorporated early in a patient’s treatment plan. He emphasized that proactive, coordinated intervention significantly enhances...
Earl M. Johnson, Jr., MD, FACS, presented a discussion on the transformative role plastic surgery can play when incorporated early in a patient’s treatment plan. He emphasized that proactive, coordinated intervention significantly enhances...
Earl M. Johnson, Jr., MD, FACS,...
08/15/2025
Vascular Disease Management
Caroline Fife, MD
AMP 2025
Estimating the Problem of Chronic Wounds
08/15/2025
Caroline E. Fife, MD, FAAFP, CWS, FUHM
Caroline E. Fife, MD, underscored how gaps in diagnosis coding, classification disagreements, and underreporting distort both prevalence and cost estimates, leading to inadequate attention and funding.
Caroline E. Fife, MD, underscored how gaps in diagnosis coding, classification disagreements, and underreporting distort both prevalence and cost estimates, leading to inadequate attention and funding.
Caroline E. Fife, MD,...
08/15/2025
Vascular Disease Management
Abigail Mize
AMP 2025
The Role of Ultrasound in Identifying and Treating Complications
08/15/2025
Abigail Mize, BS, RDCS, RVT
Abigail Mize, BS, RDCS, RVT, gave a presentation entitled "Utilization of Ultrasound to Identify and Treat Complications." She emphasized that while prevention remains the best strategy, complications can arise even with the most skilled...
Abigail Mize, BS, RDCS, RVT, gave a presentation entitled "Utilization of Ultrasound to Identify and Treat Complications." She emphasized that while prevention remains the best strategy, complications can arise even with the most skilled...
Abigail Mize, BS, RDCS, RVT,...
08/15/2025
Vascular Disease Management
Dr Brodmann
AMP 2025
Transradial Access Shifts the Paradigm in Treating Chronic Limb-Threatening Ischemia
08/14/2025
Marianne Brodmann, MD
Marianne Brodmann, MD, delivered a detailed update on how she employs radial artery access to manage chronic limb-threatening ischemia.
Marianne Brodmann, MD, delivered a detailed update on how she employs radial artery access to manage chronic limb-threatening ischemia.
Marianne Brodmann, MD, delivered...
08/14/2025
Vascular Disease Management
Dr Pliagas
AMP 2025
How IVUS Changed My Intervention
08/14/2025
George Pliagas, MD, FACS, FRCSC
During Thursday’s “Diagnosis and Imaging in CLTI” session, George Pliagas, MD, FACS, FRCSC, shared how IVUS has reshaped his approach to treating peripheral vascular disease.
During Thursday’s “Diagnosis and Imaging in CLTI” session, George Pliagas, MD, FACS, FRCSC, shared how IVUS has reshaped his approach to treating peripheral vascular disease.
During Thursday’s “Diagnosis and...
08/14/2025
Vascular Disease Management
Dr Foster
AMP 2025
Novel Radiation Shielding Device Shows Dramatic Drops in Operator Radiation in an OBL Setting
08/14/2025
Robert Foster, MD
Robert Foster, MD, discusses a study that addresses how to protect clinicians from scatter radiation without the toll of heavy lead garments.
Robert Foster, MD, discusses a study that addresses how to protect clinicians from scatter radiation without the toll of heavy lead garments.
Robert Foster, MD, discusses a...
08/14/2025
Vascular Disease Management
Dr Roy
AMP 2025
Cross-Sectional Imaging is Reshaping CLTI Care
08/14/2025
Trisha Roy, MD, PhD, FACS
Trisha Roy, MD, PhD, FACS, outlines why modern cross-sectional imaging performed before peripheral vascular intervention can be the difference between limb salvage and treatment failure in patients with CLTI.
Trisha Roy, MD, PhD, FACS, outlines why modern cross-sectional imaging performed before peripheral vascular intervention can be the difference between limb salvage and treatment failure in patients with CLTI.
Trisha Roy, MD, PhD, FACS,...
08/14/2025
Vascular Disease Management
Dr Tokuda
AMP 2025
Atherectomy + DCB vs Stent-Based Repair for Severely Calcified Femoropopliteal Disease
08/13/2025
Takahiro Tokuda, MD
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro...
08/13/2025
Vascular Disease Management
Dr Zeller
AMP 2025
WOUNDSinCLTI Trial Update: Pathogen-Driven Insights Into Limb Salvage in CLTI
08/13/2025
Thomas Zeller, MD, PhD
Thomas Zeller, MD, from the Universitaets-Herzzentrum Freiburg, Bad Krozingen, Germany, presented the inaugural findings from the WOUND infection and clinical outcomeS IN patients with Chronic Limb-Threatening Ischemia (WOUNDSinCLTI) study,
Thomas Zeller, MD, from the Universitaets-Herzzentrum Freiburg, Bad Krozingen, Germany, presented the inaugural findings from the WOUND infection and clinical outcomeS IN patients with Chronic Limb-Threatening Ischemia (WOUNDSinCLTI) study,
Thomas Zeller, MD, from the...
08/13/2025
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

AMBITION BTK TRIAL FOR CLTI
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
07/24/2025
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective,...
07/24/2025
Vascular Disease Management
Retrievable Stents
CIS and Terrebonne General are First in Louisiana to Use the Spur® Peripheral Retrievable Stent System to Treat Artery Disease Below the Knee
06/16/2025
JUNE 16, 2025 – HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the Spur® Peripheral Retrievable Stent System to treat chronic...
JUNE 16, 2025 – HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the Spur® Peripheral Retrievable Stent System to treat chronic...
JUNE 16, 2025 – HOUMA, LA –...
06/16/2025
Vascular Disease Management
VAM25
New Study Finds GLP-1 Medications Decrease Risk of Major Cardiovascular Events and Amputations for Patients With Moderate Peripheral Artery Disease
06/06/2025
NEW ORLEANS, LA, JUNE 6, 2025 – A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of...
NEW ORLEANS, LA, JUNE 6, 2025 – A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of...
NEW ORLEANS, LA, JUNE 6, 2025 –...
06/06/2025
Vascular Disease Management
Drug-Coated Balloons
Cardiovascular Institute of the South Is First in the World to Use New Drug-Coated Balloon to Treat Leg Artery Blockages
05/27/2025
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr....
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr....
May 24, 2024 – Lafayette,...
05/27/2025
Vascular Disease Management
Lower-extremity intervention
First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using R3 Vascular's Magnitude Drug-Eluting Bioresorbable Scaffold
04/22/2025
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its...
04/22/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
Critical Limb Ischemia
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
01/30/2025
The Auryon laser can be used to treat all infrainguinal lesion types, including above-the-knee (ATK), below-the-knee (BTK) and In-Stent Restenosis (ISR)3-6 and to date, it has been used to treat more than 100,000 patients7 in the United...
The Auryon laser can be used to treat all infrainguinal lesion types, including above-the-knee (ATK), below-the-knee (BTK) and In-Stent Restenosis (ISR)3-6 and to date, it has been used to treat more than 100,000 patients7 in the United...
The Auryon laser can be used to...
01/30/2025
Vascular Disease Management
Bioresorbable Scaffolds
R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDE Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
01/13/2025
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “R3 Vascular’s novel approach in the design of its next generation bioresorbable drug eluting scaffold is of great interest to the physician community and has...
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “R3 Vascular’s novel approach in the design of its next generation bioresorbable drug eluting scaffold is of great interest to the physician community and has...
Eric A. Secemsky, MD, MSc, lead...
01/13/2025
Vascular Disease Management
Clot-Sensing Guidewire
Sensome Announces Data From Two New Studies Showing Clot-Sensing Guidewire Successfully Identifies Fresh Clot to Support Decision-Making in Peripheral Artery Disease Treatment
12/13/2024
Data showcased in two late-breaking clinical trial presentations at Paris Vascular Insights Course PARIS – December 13, 2024 – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced...
Data showcased in two late-breaking clinical trial presentations at Paris Vascular Insights Course PARIS – December 13, 2024 – Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced...
Data showcased in two...
12/13/2024
Vascular Disease Management
News
CIS & IMC Are First in Acadiana to Use New Dissolvable Esprit™ System to Treat Artery Disease Below the Knee
11/25/2024
NEW IBERIA, LA – Cardiovascular Institute of the South (CIS) and Iberia Medical Center (IMC) are the first in Acadiana to use the new FDA-approved Esprit™ BTK (Below the Knee) Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind...
NEW IBERIA, LA – Cardiovascular Institute of the South (CIS) and Iberia Medical Center (IMC) are the first in Acadiana to use the new FDA-approved Esprit™ BTK (Below the Knee) Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind...
NEW IBERIA, LA – Cardiovascular...
11/25/2024
Vascular Disease Management
Peripheral IVL
Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter Launched in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions
09/16/2025
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin Peripheral IVL catheter helps address one of the most persistent technical barriers in complex below the knee (BTK) revascularization – the ‘device-uncrossable’ calcified lesion,” said Dr. Narayanan Thulasidasan
“The Shockwave Javelin...
09/16/2025
Cath Lab Digest
Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Robotic Systems
Microbot Medical Receives FDA 510(k) Clearance for Its Liberty Endovascular Robotic System
09/08/2025
The LIBERTY pivotal study showed 100% success in the robotic navigation to target, and zero device-related adverse events. The study also showed a 92% relative reduction in physician radiation exposure.
The LIBERTY pivotal study showed 100% success in the robotic navigation to target, and zero device-related adverse events. The study also showed a 92% relative reduction in physician radiation exposure.
The LIBERTY pivotal study showed...
09/08/2025
Cath Lab Digest
PAD Pulse Alliance
Peripheral Artery Disease (PAD) Awareness Month Urges Screening and Advocacy in National Effort to Prevent Amputations
09/04/2025
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed...
09/04/2025
Cath Lab Digest
Pulmonary Embolism
Imperative Care Announces FDA Clearance of Symphony Thrombectomy System, the First Large-Bore Continuous Vacuum System for Treatment of Pulmonary Embolism
09/04/2025
This clearance expands the use of Symphony — previously for the treatment of venous thrombosis — to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE)...
This clearance expands the use of Symphony — previously for the treatment of venous thrombosis — to now include PE, providing a comprehensive solution to effectively and efficiently treat the full spectrum of venous thromboembolism (VTE)...
This clearance expands the use...
09/04/2025
Cath Lab Digest
Renal Denervation
Medtronic Receives Approval for Symplicity Spyral Renal Denervation System in Japan
09/02/2025
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure...
09/02/2025
Cath Lab Digest
News
Final Patient Treated in ZENITH® FENESTRATED+ Endovascular Graft Clinical Study
08/28/2025
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL DEVICE. Limited by United States law to investigational use.     Bloomington, Ind. — Cook Medical has enrolled the final patient in the global clinical study of the ZENITH® FENESTRATED+ Endovascular...
CAUTION – INVESTIGATIONAL...
08/28/2025
Vascular Disease Management
Bioresorbable Scaffolds
Abbott's Esprit BTK Everolimus-Eluting Resorbable Scaffold System Receives CE Mark, Pioneering a New Era in Peripheral Vascular Treatment
08/26/2025
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked...
08/26/2025
Cath Lab Digest
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use